Literature DB >> 18510694

Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis.

K Ivory1, S J Chambers, C Pin, E Prieto, J L Arqués, C Nicoletti.   

Abstract

BACKGROUND: Changes in the composition of the gut microbiota have been implicated in the pathogenesis of allergic disorders, suggesting beneficial interactions between the intestinal immune system and specific bacterial strains. Lactobacilli are naturally present within the complex gastrointestinal microbiota of humans and they are currently present in many probiotic supplements.
OBJECTIVE: We sought to investigate the role that Lactobacillus casei Shirota (LcS) may play in modulating seasonal allergic rhinitis (SAR).
METHODS: The study format was double-blinded, placebo-controlled with 10 SAR sufferers in each group. We have documented and compared changes in immune status arising through the daily ingestion of a milk drink with or without live LcS, over a period of 5 months. Pre-, peak- and post-grass pollen season blood samples were collected for determination of plasma total IgE and grass pollen-specific IgG and IgE levels by an enzyme immunoassay. At the same time, cytokine levels were determined by flow cytometric bead array technology following culture of peripheral blood mononuclear cells for 6 days in the presence or absence of specific grass pollen antigens.
RESULTS: Volunteers treated with LcS showed a significant reduction in levels of antigen-induced IL-5, IL-6 and IFN-gamma production compared with volunteers supplemented with placebo. Meanwhile, levels of specific IgG increased and IgE decreased in the probiotic group.
CONCLUSION: Changes in antigen-induced production of cytokines were observed in patients treated with probiotics. These data show that probiotic supplementation modulates immune responses in allergic rhinitis and may have the potential to alleviate the severity of symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510694     DOI: 10.1111/j.1365-2222.2008.03025.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  48 in total

1.  Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.

Authors:  H Dong; I Rowland; K M Tuohy; L V Thomas; P Yaqoob
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data.

Authors:  O Ozdemir
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

3.  Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers.

Authors:  Honglin Dong; Ian Rowland; Linda V Thomas; Parveen Yaqoob
Journal:  Eur J Nutr       Date:  2013-01-10       Impact factor: 5.614

4.  Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Authors:  D J Costa; P Marteau; M Amouyal; L K Poulsen; E Hamelmann; M Cazaubiel; B Housez; S Leuillet; M Stavnsbjerg; P Molimard; S Courau; J Bousquet
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

5.  rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Toto; Manuela Iezzi; Cosmo Rossi; Stefania Zanotta; Gianni Mistrello; Ivan Zanoni; Francesca Granucci; Stefania Arioli; Diego Mora; Simone Guglielmetti; Roberto Paganelli; Mario Di Gioacchino
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

Review 6.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

7.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 8.  Gut microbiome, gut function, and probiotics: Implications for health.

Authors:  Neerja Hajela; B S Ramakrishna; G Balakrish Nair; Philip Abraham; Sarath Gopalan; Nirmal K Ganguly
Journal:  Indian J Gastroenterol       Date:  2015-04-29

Review 9.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

Review 10.  Immunomodulation by food: promising concept for mitigating allergic disease?

Authors:  Harry Wichers
Journal:  Anal Bioanal Chem       Date:  2009-05-20       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.